Vigabatrin
Infantile Spasms
AmzellSmall moleculePhase 4 / ApprovedActive
BB
66/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 51/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Infantile Spasms cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Prednisolone University of California, Los Angeles | Phase 4 | BBB |
Corticotropin All India Institute of Medical Sciences | Phase 4 | BBB |
PYRIDOXOL Lady Hardinge Medical College | Phase 3 | BB |
Benzeneethanamine, N-ethyl-?-methyl-4-(trifluoromethyl)-, hydrochloride, (±)- Children's Hospital of Orange County | Phase 3 | BB |
gwp42003-p Jazz Pharmaceuticals | Phase 3 | BB |
View all 18 →
Same molecule, other indications
Vigabatrin is also rated in:
benign partial epilepsy of infancy with complex partial seizuresDormant
B
Indicative · Phase 4
62 / 100
View asset →metabolic dysfunction-associated steatotic liver diseaseActive
B
Indicative · Phase 2
57 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →